FI114466B - Menetelmä terapeuttisesti käyttökelpoisten fenoksifenyylisyklopentenyylihydroksiureayhdisteiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten fenoksifenyylisyklopentenyylihydroksiureayhdisteiden valmistamiseksi Download PDF

Info

Publication number
FI114466B
FI114466B FI943799A FI943799A FI114466B FI 114466 B FI114466 B FI 114466B FI 943799 A FI943799 A FI 943799A FI 943799 A FI943799 A FI 943799A FI 114466 B FI114466 B FI 114466B
Authority
FI
Finland
Prior art keywords
compounds
formula
hydroxyurea
phenyl
cyclopenten
Prior art date
Application number
FI943799A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943799A (fi
FI943799A0 (fi
Inventor
Akiyoshi Kawai
Rodney W Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943799A0 publication Critical patent/FI943799A0/fi
Publication of FI943799A publication Critical patent/FI943799A/fi
Application granted granted Critical
Publication of FI114466B publication Critical patent/FI114466B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
FI943799A 1993-08-19 1994-08-18 Menetelmä terapeuttisesti käyttökelpoisten fenoksifenyylisyklopentenyylihydroksiureayhdisteiden valmistamiseksi FI114466B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20545393 1993-08-19
JP20545393 1993-08-19

Publications (3)

Publication Number Publication Date
FI943799A0 FI943799A0 (fi) 1994-08-18
FI943799A FI943799A (fi) 1995-02-20
FI114466B true FI114466B (fi) 2004-10-29

Family

ID=16507136

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943799A FI114466B (fi) 1993-08-19 1994-08-18 Menetelmä terapeuttisesti käyttökelpoisten fenoksifenyylisyklopentenyylihydroksiureayhdisteiden valmistamiseksi

Country Status (27)

Country Link
US (1) US5792882A (no)
EP (1) EP0720598B1 (no)
JP (1) JP2794343B2 (no)
KR (1) KR0170623B1 (no)
CN (1) CN1077568C (no)
AT (1) ATE171939T1 (no)
AU (1) AU674776B2 (no)
BR (1) BR9407314A (no)
CA (1) CA2169066C (no)
CO (1) CO4230229A1 (no)
CZ (1) CZ288358B6 (no)
DE (1) DE69413831T2 (no)
DK (1) DK0720598T3 (no)
EC (1) ECSP941144A (no)
EG (1) EG20530A (no)
ES (1) ES2121218T3 (no)
FI (1) FI114466B (no)
IL (1) IL110628A (no)
MY (1) MY111140A (no)
NO (1) NO305595B1 (no)
NZ (1) NZ269849A (no)
PE (1) PE57194A1 (no)
PL (1) PL176223B1 (no)
RU (1) RU2125987C1 (no)
TW (2) TW418089B (no)
WO (1) WO1995005360A1 (no)
ZA (1) ZA946253B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL317873A1 (en) * 1994-06-27 1997-04-28 Cytomed Inc Compounds for and method of treating cardiovascular, inflammatory and immunological disorders
EP0790981B1 (en) * 1994-11-10 1999-09-08 Pfizer Inc. Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
WO1996016054A1 (en) * 1994-11-18 1996-05-30 Pfizer Pharmaceuticals Inc. Cycloalkenyl-n-hydroxyureas
EP1745774A3 (en) 1997-08-11 2007-04-11 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6121323A (en) * 1997-12-03 2000-09-19 3M Innovative Properties Company Bishydroxyureas
KR100879423B1 (ko) 2004-12-02 2009-01-19 (주)아모레퍼시픽 Ｔｎｆ-알파의 생산을 저해하는 2-사이클로펜텐-1-온 옥심유도체
KR101567571B1 (ko) 2007-12-03 2015-11-11 (주)아모레퍼시픽 2-사이클로펜텐-1-온 옥심 유도체를 유효성분으로 포함하는 슬리밍 화장료 조성물
ES2552386T3 (es) 2009-04-03 2015-11-27 F. Hoffmann-La Roche Ag Composiciones de {3-[5-(4-cloro-fenil)-1H-pirrol[2,3-b]piridin-3-carbonil]-2,4-difluoro-fenil}-amida del ácido propano-1-sulfónico y usos de las mismas
US8512464B2 (en) * 2009-12-02 2013-08-20 3M Innovative Properties Company Functionalized zirconia nanoparticles and high index films made therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
HU208523B (en) * 1989-02-03 1993-11-29 Wellcome Found Process for producing antiphlogistic aryl-compounds and pharmaceutical compositions containing them
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途
JPH05163229A (ja) * 1991-12-13 1993-06-29 Pfizer Pharmaceut Co Ltd 新規なシクロプロピル誘導体
JPH05294921A (ja) * 1992-04-17 1993-11-09 Pfizer Pharmaceut Co Ltd 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Also Published As

Publication number Publication date
JP2794343B2 (ja) 1998-09-03
CN1129440A (zh) 1996-08-21
DE69413831T2 (de) 1999-02-25
NO960631D0 (no) 1996-02-16
EP0720598B1 (en) 1998-10-07
BR9407314A (pt) 1996-04-16
TW448144B (en) 2001-08-01
PE57194A1 (es) 1995-02-07
EP0720598A1 (en) 1996-07-10
CA2169066A1 (en) 1995-02-23
IL110628A0 (en) 1994-11-11
MY111140A (en) 1999-08-30
FI943799A (fi) 1995-02-20
KR0170623B1 (ko) 1999-03-30
DE69413831D1 (de) 1998-11-12
IL110628A (en) 1998-12-27
CO4230229A1 (es) 1995-10-19
RU2125987C1 (ru) 1999-02-10
PL176223B1 (pl) 1999-05-31
ES2121218T3 (es) 1998-11-16
NO960631L (no) 1996-02-16
ZA946253B (en) 1996-02-19
US5792882A (en) 1998-08-11
NO305595B1 (no) 1999-06-28
PL313037A1 (en) 1996-05-27
NZ269849A (en) 1997-10-24
FI943799A0 (fi) 1994-08-18
ATE171939T1 (de) 1998-10-15
DK0720598T3 (da) 1999-06-21
EG20530A (en) 1999-07-31
WO1995005360A1 (en) 1995-02-23
JPH08511031A (ja) 1996-11-19
KR960703845A (ko) 1996-08-31
AU7350994A (en) 1995-03-14
CN1077568C (zh) 2002-01-09
TW418089B (en) 2001-01-11
CA2169066C (en) 1999-06-22
ECSP941144A (es) 1995-02-27
CZ288358B6 (en) 2001-05-16
AU674776B2 (en) 1997-01-09
CZ48396A3 (en) 1996-07-17

Similar Documents

Publication Publication Date Title
US7947675B2 (en) Trifluoromethylbenzamide derivatives and therapeutic uses thereof
CA2899088A1 (en) Thiazole and oxazole compounds as glycosidase inhibitors
NO179582B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive hydroksamsyre- og N-hydroksyurinstoff-derivater
PL171921B1 (pl) Sposób wytwarzania nowych pochodnych podstawionej 3-aminochinuklidyny PL PL PL PL PL
US10280159B2 (en) Fused (hetero)cyclic compounds as S1P modulators
EP0581167B1 (en) Novel arylglycinamide derivatives and preparative processes therefor and their use for treatment of dysuria
FI114466B (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksifenyylisyklopentenyylihydroksiureayhdisteiden valmistamiseksi
KR20090107083A (ko) 오렉신 길항제로서의 아미노아마이드
EP2745876A1 (en) Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
JP2007534616A (ja) アセチルコリンエステラーゼの阻害薬としてのタクリン誘導体
WO1994018165A1 (en) Sulfonamide compounds as opioid k-receptor agonists
FI113643B (fi) Aryylioksisykloalkenyyli- ja aryylioksi-iminosykloalkenyylihydroksiureat 5-lipoksygenaasin inhibiittoreina
US6037355A (en) Imidazole lipoxygenase inhibitors
JP2756732B2 (ja) リポキシゲナーゼ阻害剤としてのフェニルチオフェニルシクロアルケニルヒドロキシ尿素
WO1996016054A1 (en) Cycloalkenyl-n-hydroxyureas
US9388181B2 (en) Substituted 1,2,3,4-tetrahydropyrido[3,4-E] pyrrolo[1,2-A]pyrimidines as kinase
WO1994018158A1 (en) Spiroalkylhydroxyureas for use as lipoxygenase inhibitors
JP2000001433A (ja) ５―リポキシゲナ―ゼ阻害剤
JP2020186182A (ja) 標的蛋白質分解誘導化合物
JP2009519300A (ja) カルシウムチャネルブロッカーとしてのジベンゼン誘導体
MXPA98002940A (es) Metilfeniloxazolidinonas quirales

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114466

Country of ref document: FI

MA Patent expired